References
- Cesura A. M., Pletscher A. The new generation of monoamine oxidase inhibitors. Progress in Drug Research 1992; 38: 171–297
- Da Prada M., Kettler R., Keller H. H., Burkard W. P., Muggli-Maniglio D., Haefely W. E. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics 1989; 248: 400–414
- De Sousa G., Dou M., Barbe D., Lacarelle B., Placidi M., Rahmani R. Freshly isolated or cryopreserved human hepatocytes in primary culture: influence of drug metabolism on hepatotoxicity. Toxicology, in vitro 1991; 5/6: 483–486
- Dou M., De Sousa G., Lacarelle B., Placidi M., Porte De La, Lechene P., Domingo M., Lafont H., Rahmani R. Thawed human hepatocytes in primary culture. Cryobiology 1992; 29: 454–469
- Fabre G., Rahmani R., Placidi M., Combalbert J., Covo J., Cano J.-P., Coulange C., Ducros M., Rampal M. Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers. Biochemical Pharmacology 1988; 37(22)4389–4397
- Jauch R., Griesser E., Oesterhelt G., Arnold W., Meister W., Ziegler W. H., Guentert T. W. Biotransformation of moclobemide in humans. Acta Psychiatrica Scandinavica 1990a; 360: 87–90, Suppl.
- Jauch R., Schmid P., Griesser E., Lengsfeld H., Fleury A. Metabolite pattern of moclobemide in rats: comparison of in vivo and in vitro results. Twelfth European Workshop on Drug Metabolism, Basel 1990b, Abstract
- Knoll J., Magyar K. Some puzzling pharmacological effect of monoamine oxidase inhibitors. Advances in Biochemical Psychopharmacology 1972; 5: 393–408
- Lacarelle B., Marre F., Durand A., Davi H., Rahmani R. Metabolism of minaprine in human and animal hepatocytes and liver microsomes—prediction of metabolism in vivo. Xenobiotica 1991; 21: 317–329
- Lavrijsen K., Van Houdt J., Van Dyck D., Hendrickx J., Bockx M., Hurkmans R., Meuldermans W., Le Jeune L., Lauwers W., Heykants J. Comparative metabolism of flunarizine in rats, dogs and man: an in vitrostudy with subcellular liver fractions and isolated hepatocytes. Xenobiotica 1992; 22: 815–836
- Lavrijsen K., Van Houdt J., Van Dyck D., Hendrickx J., Lauwers W., Hurkmans R., Bockx M., Janssen C., Meuldermans W., Heykants J. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans. Drug Metabolism and Disposition 1990; 18: 704–710
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Norman T. R., Ames D., Burrows G. D., Davies B. A controlled study of a specific and reversible inhibitor (Ro 11–1163) and amitriptyline in depressive illness. Journal of Affective Disorders 1985; 8: 29–35
- Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2379–2385
- Postma J. U., Vranesic D. Moclobemide in the treatment of depression in demented geriatric patients. Acta Therapeutica 1985; 11: 1–4
- Rahmani R., Richard B., Fabre G., Cano J.-P. Extrapolation of preclinical pharmacokinetic data to therapeutic drug use. Xenobiotica 1988; 18: 71–78
- Schoerlin M.-P., Da Prada M. Species-specific biotransformation of moclobemide: a comparative study in rats and humans. Acta Psychiatrica Scandinavica 1990; 360: 108–110, Suppl.
- Seglen P. O. Preparation of isolated liver cells. Methods in Cell Biology, D. M. Prescott. Academic, New York 1976; Vol. 13: 29–83
- Yang H. Y., Neff N. H. The monoamine oxidase of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 365–371